SCHEMBL6733518

SCHEMBL6733518

CCOC(=O)c1ccc(N(OC(C)(C)C)C(=O)OC(C)(C)C)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HPGD P15428 5/20 0.36
ALDH1A1 P00352 4/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
TSHR P16473 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.35
POLB P06746 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9041997 0.78 HDAC3 (0.43) HDAC3HDAC4HDAC1HDAC6HPGD
SCHEMBL9042699 0.77 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC6HPGD
SCHEMBL6361757 0.74 HDAC3 (0.55) HDAC3HDAC4HDAC1HDAC6HPGD
SCHEMBL9042261 0.74 HDAC3 (0.39) HDAC3HDAC4HDAC1HDAC6HPGD
SCHEMBL9042256 0.74 HDAC3 (0.39) HDAC3HDAC4HDAC1HDAC6HPGD
SCHEMBL6323915 0.73 GPR119 (0.38)
SCHEMBL7018973 0.72 HDAC3 (0.73) HDAC3HDAC4HDAC1HDAC6HPGD
SCHEMBL8704326 0.69 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC6HPGD
SCHEMBL6865108 0.69 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC6HPGD
SCHEMBL28211212 0.69 HPGD (0.46) HPGDALDH1A1L3MBTL1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242591-A1 Oxazolidinone derivatives as pontential antimicrobials RANBAXY LABORATORIES LIMITED (IN) 2004-12-02 US disclosed
EP-1409464-A1 OXAZOLIDINONE DERIVATIVES AS POTENTIAL ANTIMICROBIALS RANBAXY LABORATORIES, LTD. (IN) 2004-04-21 EP disclosed
WO-2003008389-A1 OXAZOLIDINONE DERIVATIVES AS POTENTIAL ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2003-01-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242591-A1 Oxazolidinone derivatives as pontential antimicrobials PDK4, OXA1L, PPARD HDAC3 741/4885HDAC4 377/4885HDAC1 825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.